Multiple Choice
A current problem in modern medicine is the development of drug resistance mutations.This occurs when a mutation arises in a disease-causing microbe making it resistant to a drug and thus rendering the drug useless in treating a specific disease.Many useful drugs are competitive inhibitors of specific enzymes, and the drug-resistance mutations prevent the binding of the drug.These types of mutations, in addition to preventing competitive inhibitor binding, can also sometimes reduce the activity of the enzyme.Why is that the case? rev: 01_20_2015_QC_CS-4567
A) Binding to the competitive inhibitor is essential for the function of the enzyme
B) These mutations most likely affect an allosteric site on the enzyme
C) These mutations lower the activation energy of the reaction catalyzed by the enzyme
D) These mutations most likely change the shape of the active site of the enzyme
Correct Answer:

Verified
Correct Answer:
Verified
Q5: While standing at the top of the
Q6: Phosphofructokinase (PFK) is an enzyme that converts
Q7: Why do we have storage macromolecules,such as
Q8: The term oxidation is derived from the
Q11: A new antibiotic has been developed that
Q17: You return home to find that your
Q34: You are working with a specific enzyme-catalyzed
Q39: Tacrolimus (FK-506)is a drug that inhibits an
Q44: The energy needed to destabilize existing chemical
Q48: A particular chemical reaction is exergonic.What can